Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBC
N/A
To explore the real world situation of trastuzumab and lapatinib combined c...
Status
Completed
Location
Biyun Wang, MD
Start Date
2015-01-01
Trial ID
NCT04001634
A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
PHASE1
This study will characterize the effect of elevated gastric pH mediated by ...
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
PHASE2
This randomized phase II trial studies how well whole-brain radiation thera...
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
PHASE2
HER2 is a protein that sits on the surface of breast cancer cells in some p...
Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
PHASE1
The purpose of this study is to see if capecitabine can be taken safely wit...